Skip to main content
RecallFDAfda-F-0891-2023UNDECLARED ALLERGEN

Duke's SOUTHERN SAUCES BAYOU REMOULADE NET WT. 10 FL OZ (296 ml) GLUTEN FREE INGREDIENTS:***SOY SAUCE (WHEAT, SOYBEANS, AND SALT)***CONTA...

Category
Units Affected
340
Recall Date
March 17, 2023
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0891-2023.

The firm was notified by a consumer that the product label is incorrect. The label says, "Gluten Free" however the product contains wheat.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0891-2023.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Sauer Brands, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0891-2023.

Sauer Brands, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Sauer Brands, Inc. Recall FAQ

Sauer Brands, Inc. is the subject of a food safety report: Duke's SOUTHERN SAUCES BAYOU REMOULADE NET WT. 10 FL OZ (296 ml) GLUTEN FREE INGREDIENTS:***SOY SAUCE (WHEAT, SOYBEANS, AND SALT)***CONTA.... The notice was published on March 17, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 340 units are potentially affected.